期刊
ONCOTARGET
卷 6, 期 14, 页码 12493-12504出版社
IMPACT JOURNALS LLC
DOI: 10.18632/oncotarget.3722
关键词
melanoma; tumor vaccine; interleukin-21; transforming growth factor beta 1; miR200c
资金
- National Natural Science Foundation of China [81071769, 81202372]
- China Postdoctoral Science Foundation [2013M530227]
- Graduate Research and Innovation Projects in Jiangsu Province of China [KYLX_0195]
- Jiangsu Planned Projects for Postdoctoral Research Funds [1301099C]
- Nantong Planned Projects for applied research [BK2012067]
TGF-beta 1 secreted abundantly by tumors cells as well as present in the local microenvironment promotes neoplasm invasion and metastasis by triggering the epithelial to mesenchymal transition (EMT). MiR200c has been shown to suppress EMT and to regulate the cellular epithelial and interstitial state conversion, whereas the tumor vaccines are intended to specifically initiate or amplify a host response against evolving tumor cells. Our study aimed at optimizing the antitumor effects of the B16F10/glycosylphosphatidylinositol-interleukin 21 (B16F10/GPI-IL-21) tumor vaccine on melanoma bearing mice by combining the TGF-beta 1 knockdown and the administration of miR200c agomir. The mice were subcutaneously vaccinated with inactivated B16F10/GPI-IL-21 vaccine and challenged by B16F10 cells transfected with shTGF-beta 1 (B16F10/shTGF-beta 1 cells) or B16F10/shTGF-beta 1 cells with the administration of miR200c agomir. The later combination showed that, when compared with the mice in the control group that received no vaccination, vaccinated mice significantly increased NK and CTL activities, enhanced levels of IFN-gamma, and reduced expression of TGF-beta 1, N-cadherin, Vimentin, Gli1/2, P-Smad2/3 and others involved in promoting expression of EMT-related molecules in tumor areas, and inhibited the melanoma metastasis in lungs and lymph nodes. Altogether, our findings demonstrate that this synergistic anti-cancer regimen effectively induces strong immune response and diminishes the melanoma progression.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据